Abstract

Abstract Introduction: Clinical and molecular heterogeneity are hallmarks that distinguish each of the five major ovarian carcinoma histotypes. High-grade serous ovarian carcinomas (HGSC) are by far the most prominent type (70%) and thought to arise from the fallopian tube and appear driven by DNA damage phenotypes with high levels of copy number change. The second and third most common types are clear cell (CCOC) and endometrioid (ENOC) (20-25%), both of which are known to originate from endometriosis, with emerging evidence of molecular substructure in each type. Using an-omics approaches we regulatory elements and resulting expression signatures across tumor-epithelium and stromal compartments of these three most common histologies. Methods: We performed compartment-specific laser-capture microdissection and conducted methylation and gene expression sequencing on 75 fresh frozen primary tumor samples from each of CCOC, HGSC, ENOC (20 per subtype). Immunohistochemistry was used to determine the state of common molecular markers (e.g., WT1, p53, HNF1B, ER, PR). Results Preliminary RNA-Seq data complements previous findings in the bulk tissue analysis: WT1 is highly overexpressed in HGSC, HFN1B is overexpressed in CCOC and high ESR1-levels and low HAVCR1 expression can be found comparing ENOC with CCOC tissue. In the stroma differential gene expression overall had smaller logFC, however, CLCN2 was low in CCOC and HGSC compared to ENOC and MYH2/14 was significantly higher in both endometriosis-associated types. Estimations of immune cell infiltration (CIBERSORT) showed a gradual immune response between compartments and histotypes, with highest involvement seen in (stromal) HGSC. Beside multiple collagen genes, THBS1 has been highly expressed in stroma across all histotypes which can be targeted with approved drugs. Curiously, the epigenetic analysis showed that there is little variation in the stroma across these histotype, with similar to what was seen in the transcriptome. Conclusion: The tumor epithelial compartments of HGSC, ENOC, and CCOC showed unique regulatory signatures, consistent with previous bulk analysis. In contrast we observed relatively little heterogeneity in the stromal compartments, suggesting the tumor associated fibroblast component in particular may play a passive role in tumor progression and may contribute less to observed regulatory signatures. Nonetheless, this uniformity in gene expression may be exploited with pan-ovarian carcinoma treatment strategies. Citation Format: Karolin Heinze, Ian Beddows, Bianca Ribeiro de Souza, Hui Shen, Martin Koebel, Michael S. Anglesio. Precision medicine opportunities: uniformity across stromal components of ovarian cancer histotype contrasts heterogeneous disease [abstract]. In: Proceedings of the AACR Special Conference on Ovarian Cancer; 2023 Oct 5-7; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(5 Suppl_2):Abstract nr B004.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.